Tapewire

Nasdaq · USD

AKBA

Akebia Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6105
SEC CIK
0001517022
Parsed reports
275

Last 12 months

Inside the activity.

1 purchase rows · 16 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 2026015
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 06, 2024 Filed Jun 10, 2024 20:19 UTC
FRIESON RONDirector
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-004905 · primarydocument.xml · nonDerivative · entry 1

FRIESON RON · CIK 0001890219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,700

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
May 13, 2024 Filed May 14, 2024 16:04 UTC
Dahan MichelSVP, Chief Operating Officer
SaleCommon Stock 34,840 $1.26 $43,898.40
Disclosure

SEC source: 0001562180-24-004025 · primarydocument.xml · nonDerivative · entry 1

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 672,092

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on May 12, 2023.

F2 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2023.

Read SEC document
May 13, 2024 Filed May 14, 2024 20:05 UTC
Hadas Nicole R.SVP, Chief Legal Officer
SaleCommon Stock 12,016 $1.26 $15,140.16
Disclosure

SEC source: 0001562180-24-004026 · primarydocument.xml · nonDerivative · entry 1

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 651,243

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on May 12, 2023.

F2 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2023.

Read SEC document
February 29, 2024 Filed Mar 1, 2024 17:49 UTC
Dahan MichelSVP, Chief Operating Officer
SaleCommon Stock 8,661 $1.58 $13,684.38
Disclosure

SEC source: 0001562180-24-002023 · primarydocument.xml · nonDerivative · entry 1

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 706,932

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.

Read SEC document
February 29, 2024 Filed Mar 1, 2024 22:48 UTC
Hadas Nicole R.SVP, Chief Legal Officer
SaleCommon Stock 5,974 $1.58 $9,438.92
Disclosure

SEC source: 0001562180-24-002022 · primarydocument.xml · nonDerivative · entry 1

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 663,259

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.

Read SEC document
February 29, 2024 Filed Mar 1, 2024 22:47 UTC
Butler John P.Director · CEO and President
SaleCommon Stock 46,570 $1.58 $73,580.60
Disclosure

SEC source: 0001562180-24-002021 · primarydocument.xml · nonDerivative · entry 1

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,044,580

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.

Read SEC document
February 29, 2024 Filed Mar 1, 2024 22:46 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 7,169 $1.58 $11,327.02
Disclosure

SEC source: 0001562180-24-002020 · primarydocument.xml · nonDerivative · entry 1

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 695,840

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 18:02 UTC
Dahan MichelSVP, Chief Operating Officer
SaleCommon Stock 10,744 $1.52 $16,330.88
Disclosure

SEC source: 0001562180-24-001994 · primarydocument.xml · nonDerivative · entry 1

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 715,593

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 23:03 UTC
Hadas Nicole R.SVP, Chief Legal Officer
SaleCommon Stock 7,411 $1.52 $11,264.72
Disclosure

SEC source: 0001562180-24-001995 · primarydocument.xml · nonDerivative · entry 1

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 669,233

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.

F2 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2023.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 23:01 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 8,367 $1.52 $12,717.84
Disclosure

SEC source: 0001562180-24-001993 · primarydocument.xml · nonDerivative · entry 1

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 703,009

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.

F2 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 23:00 UTC
Butler John P.Director · CEO and President
SaleCommon Stock 37,733 $1.52 $57,354.16
Disclosure

SEC source: 0001562180-24-001992 · primarydocument.xml · nonDerivative · entry 1

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,091,150

F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.

Read SEC document
February 01, 2024 Filed Feb 2, 2024 21:10 UTC
Butler John P.Director · CEO and President
SaleCommon Stock 46,489 $1.68 $78,101.52
Disclosure

SEC source: 0001562180-24-000971 · primarydocument.xml · nonDerivative · entry 2

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,128,883

F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31,2023.

Read SEC document
February 01, 2024 Filed Feb 2, 2024 21:10 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 24,311 $1.68 $40,842.48
Disclosure

SEC source: 0001562180-24-000970 · primarydocument.xml · nonDerivative · entry 2

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 711,376

F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31,2023.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 16:11 UTC
Dahan MichelSVP, Chief Operating Officer
GrantStock Option (Right to buy) · Derivative 224,000 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001562180-24-000978 · primarydocument.xml · derivative · entry 2

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224,000

Underlying: Common Stock · 224,000 shares

Expires 2034-01-31

F3 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 16:11 UTC
Dahan MichelSVP, Chief Operating Officer
GrantCommon Stock 149,300 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-000978 · primarydocument.xml · nonDerivative · entry 1

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 726,337

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2023 and 1,500 shares of the Issuer's common stock purchased on December 29, 2023, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:11 UTC
Grund NicholasChief Commercial Officer
GrantStock Option (Right to buy) · Derivative 454,950 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001562180-24-000983 · primarydocument.xml · derivative · entry 2

Grund Nicholas · CIK 0001661887 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 454,950

Underlying: Common Stock · 454,950 shares

Expires 2034-01-31

F2 · derivative.exercise_date: The options were granted by the Issuer as an inducement material to the reporting person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:11 UTC
Grund NicholasChief Commercial Officer
GrantCommon Stock 303,300 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-000983 · primarydocument.xml · nonDerivative · entry 1

Grund Nicholas · CIK 0001661887 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 303,300

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:11 UTC
Malabre Richard CChief Accounting Officer
GrantStock Option (Right to buy) · Derivative 336,000 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001562180-24-000980 · primarydocument.xml · derivative · entry 2

Malabre Richard C · CIK 0002007730 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 336,000

Underlying: Common Stock · 336,000 shares

Expires 2034-01-31

F2 · derivative.exercise_date: The options were granted by the Issuer as an inducement material to the reporting person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:11 UTC
Malabre Richard CChief Accounting Officer
GrantCommon Stock 223,950 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-000980 · primarydocument.xml · nonDerivative · entry 1

Malabre Richard C · CIK 0002007730 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,950

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:10 UTC
Snow EllenSVP, CFO and Treasurer
GrantStock Option (Right to buy) · Derivative 224,000 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001562180-24-000975 · primarydocument.xml · derivative · entry 2

Snow Ellen · CIK 0001786643 · SVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224,000

Underlying: Common Stock · 224,000 shares

Expires 2034-01-31

F2 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:10 UTC
Snow EllenSVP, CFO and Treasurer
GrantCommon Stock 149,300 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-000975 · primarydocument.xml · nonDerivative · entry 1

Snow Ellen · CIK 0001786643 · SVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 519,300

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:10 UTC
Hadas Nicole R.SVP, Chief Legal Officer
GrantStock Option (Right to buy) · Derivative 224,000 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001562180-24-000973 · primarydocument.xml · derivative · entry 2

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224,000

Underlying: Common Stock · 224,000 shares

Expires 2034-01-31

F3 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:10 UTC
Hadas Nicole R.SVP, Chief Legal Officer
GrantCommon Stock 149,300 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-000973 · primarydocument.xml · nonDerivative · entry 1

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 676,644

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2023 and 1,500 shares of the Issuer's common stock purchased on December 29, 2023, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:10 UTC
Butler John P.Director · CEO and President
GrantStock Option (Right to buy) · Derivative 905,200 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001562180-24-000971 · primarydocument.xml · derivative · entry 7

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 905,200

Underlying: Common Stock · 905,200 shares

Expires 2034-01-31

F4 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:10 UTC
Butler John P.Director · CEO and President
GrantCommon Stock 603,500 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-000971 · primarydocument.xml · nonDerivative · entry 1

Butler John P. · CIK 0001591467 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,175,372

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2023 and 1,500 shares of the Issuer's common stock purchased on December 29, 2023, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:10 UTC
Burke Steven KeithSVP, Chief Medical Officer
GrantStock Option (Right to buy) · Derivative 303,300 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001562180-24-000970 · primarydocument.xml · derivative · entry 3

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 303,300

Underlying: Common Stock · 303,300 shares

Expires 2034-01-31

F4 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:10 UTC
Burke Steven KeithSVP, Chief Medical Officer
GrantCommon Stock 202,200 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-000970 · primarydocument.xml · nonDerivative · entry 1

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 735,687

F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2023 and 1,500 shares of the Issuer's common stock purchased on December 29, 2023, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan.

Read SEC document
August 25, 2023 Filed May 9, 2024 21:27 UTC
Burke Steven KeithSVP, Chief Medical Officer
SaleCommon Stock 27,000 $1.15 $31,050.00
Disclosure

SEC source: 0001562180-24-003948 · primarydocument.xml · nonDerivative · entry 1

Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 668,840

Read SEC document
July 31, 2023 Filed Aug 1, 2023 20:35 UTC
Snow EllenSVP, CFO and Treasurer
GrantStock Option (Right to buy) · Derivative 560,000 $0.00 Strike: $1.67 $0.00
Disclosure

SEC source: 0001562180-23-006088 · primarydocument.xml · derivative · entry 2

Snow Ellen · CIK 0001786643 · SVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 560,000

Underlying: Common Stock · 560,000 shares

Expires 2033-07-31

F2 · derivative.exercise_date: The options were granted by the Issuer as an inducement material to the Reporting Person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
July 31, 2023 Filed Aug 1, 2023 20:35 UTC
Snow EllenSVP, CFO and Treasurer
GrantCommon Stock 370,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-006088 · primarydocument.xml · nonDerivative · entry 1

Snow Ellen · CIK 0001786643 · SVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 370,000

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the RSUs will vest upon each of the first, second and third anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:07 UTC
Wolf MylesDirector
GrantStock Option (Right to buy) · Derivative 45,000 $0.00 Strike: $1.20 $0.00
Disclosure

SEC source: 0001562180-23-004957 · primarydocument.xml · derivative · entry 2

Wolf Myles · CIK 0001808317 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2033-06-06

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:07 UTC
Wolf MylesDirector
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004957 · primarydocument.xml · nonDerivative · entry 1

Wolf Myles · CIK 0001808317 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,681

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Second Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:07 UTC
ADAMS ADRIANDirector
GrantStock Option (Right to buy) · Derivative 45,000 $0.00 Strike: $1.20 $0.00
Disclosure

SEC source: 0001562180-23-004956 · primarydocument.xml · derivative · entry 2

ADAMS ADRIAN · CIK 0001248144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2033-06-06

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:07 UTC
ADAMS ADRIANDirector
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004956 · primarydocument.xml · nonDerivative · entry 1

ADAMS ADRIAN · CIK 0001248144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,800

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Second Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:08 UTC GrantStock Option (Right to buy) · Derivative 45,000 $0.00 Strike: $1.20 $0.00
Disclosure

SEC source: 0001562180-23-004959 · primarydocument.xml · derivative · entry 2

ROGERS MICHAEL W · CIK 0001244159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2033-06-06

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:08 UTC GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004959 · primarydocument.xml · nonDerivative · entry 1

ROGERS MICHAEL W · CIK 0001244159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,029

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Second Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:08 UTC GrantStock Option (Right to buy) · Derivative 45,000 $0.00 Strike: $1.20 $0.00
Disclosure

SEC source: 0001562180-23-004960 · primarydocument.xml · derivative · entry 2

ZUMWALT LEANNE M · CIK 0001204946 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2033-06-06

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:08 UTC GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004960 · primarydocument.xml · nonDerivative · entry 1

ZUMWALT LEANNE M · CIK 0001204946 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,700

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Second Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 16:07 UTC GrantStock Option (Right to buy) · Derivative 45,000 $0.00 Strike: $1.20 $0.00
Disclosure

SEC source: 0001562180-23-004954 · primarydocument.xml · derivative · entry 2

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2033-06-06

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 16:07 UTC GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004954 · primarydocument.xml · nonDerivative · entry 1

GILMAN STEVEN C · CIK 0001379970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,130

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Second Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:07 UTC
FRIESON RONDirector
GrantStock Option (Right to buy) · Derivative 45,000 $0.00 Strike: $1.20 $0.00
Disclosure

SEC source: 0001562180-23-004958 · primarydocument.xml · derivative · entry 2

FRIESON RON · CIK 0001890219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2033-06-06

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:07 UTC
FRIESON RONDirector
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004958 · primarydocument.xml · nonDerivative · entry 1

FRIESON RON · CIK 0001890219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,700

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Second Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:07 UTC GrantStock Option (Right to buy) · Derivative 45,000 $0.00 Strike: $1.20 $0.00
Disclosure

SEC source: 0001562180-23-004955 · primarydocument.xml · derivative · entry 2

Smith Cynthia · CIK 0001609480 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2033-06-06

F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:07 UTC GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004955 · primarydocument.xml · nonDerivative · entry 1

Smith Cynthia · CIK 0001609480 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,233

F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Second Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Read SEC document
May 25, 2023 Filed May 25, 2023 21:01 UTC
Dahan MichelSVP, Chief Operating Officer
SaleCommon Stock 95,478 $1.22 $116,760.05
Disclosure

SEC source: 0001562180-23-004503 · primarydocument.xml · nonDerivative · entry 2

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 574,037

F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of all of the PSUs.

Read SEC document
May 25, 2023 Filed May 26, 2023 01:01 UTC
Hadas Nicole R.SVP, Chief Legal Officer
SaleCommon Stock 63,186 $1.22 $77,270.16
Disclosure

SEC source: 0001562180-23-004504 · primarydocument.xml · nonDerivative · entry 2

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 524,344

F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of all of the PSUs.

Read SEC document
May 24, 2023 Filed May 25, 2023 21:01 UTC
Dahan MichelSVP, Chief Operating Officer
GrantEmployee Stock Option (Right to buy) · Derivative 200,000 $0.00 Strike: $0.41 $0.00
Disclosure

SEC source: 0001562180-23-004503 · primarydocument.xml · derivative · entry 3

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2032-05-12

F3 · derivative.exercise_date: As previously disclosed, in May 2022, the Reporting Person was granted performance-based options (the "Options") pursuant to the Issuer's 2014 Incentive Plan, as amended. The Options vest upon the closing of a significant transaction as defined in the award agreements. On May 24, 2023, the Company entered into a License Agreement, which transaction qualified as a significant transaction and closed on May 24, 2023. As a result, all of the shares subject to the Option vested on May 24, 2023.

Read SEC document
May 24, 2023 Filed May 25, 2023 21:01 UTC
Dahan MichelSVP, Chief Operating Officer
GrantCommon Stock 200,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004503 · primarydocument.xml · nonDerivative · entry 1

Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 669,515

F1 · shares: As previously disclosed, in May 2022, the Reporting Person was granted performance-based restricted stock units ("PSUs") pursuant to the Issuer's 2014 Incentive Plan, as amended. The PSUs vest upon the closing of a significant transaction as defined in the award agreement. On May 24, 2023, the Company entered into a License Agreement, which transaction qualified as a significant transaction and closed on May 24, 2023. As a result, all of the PSUs vested on May 24, 2023

Read SEC document
May 24, 2023 Filed May 26, 2023 01:01 UTC
Hadas Nicole R.SVP, Chief Legal Officer
GrantEmployee Stock Option (Right to buy) · Derivative 200,000 $0.00 Strike: $0.41 $0.00
Disclosure

SEC source: 0001562180-23-004504 · primarydocument.xml · derivative · entry 3

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2032-05-12

F3 · derivative.exercise_date: As previously disclosed, in May 2022, the Reporting Person was granted performance-based options (the "Options") pursuant to the Issuer's 2014 Incentive Plan, as amended. The Options vest upon the closing of a significant transaction as defined in the award agreements. On May 24, 2023, the Company entered into a License Agreement, which transaction qualified as a significant transaction and closed on May 24, 2023. As a result, all of the shares subject to the Option vested on May 24, 2023.

Read SEC document
May 24, 2023 Filed May 26, 2023 01:01 UTC
Hadas Nicole R.SVP, Chief Legal Officer
GrantCommon Stock 200,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004504 · primarydocument.xml · nonDerivative · entry 1

Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 587,530

F1 · shares: As previously disclosed, in May 2022, the Reporting Person was granted performance-based restricted stock units ("PSUs") pursuant to the Issuer's 2014 Incentive Plan, as amended. The PSUs vest upon the closing of a significant transaction as defined in the award agreement. On May 24, 2023, the Company entered into a License Agreement, which transaction qualified as a significant transaction and closed on May 24, 2023. As a result, all of the PSUs vested on May 24, 2023

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.